Clinical Trial Update: Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating diazoxide-mediated insulin suppression in hyperinsulinemic obese men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinism
• Obesity

Drugs mentioned

• DIAZOXIDE (DIAZOXIDE)

Snippet

Sponsor: Rijnstate Hospital | Conditions: Obesity, Hyperinsulinism | Phase 2 | Status: COMPLETED